An effective treatment for AIDS

This article was written in June 2000
and posted during the Internet Discussion
of the South African Presidential AIDS Advisory Panel

Seven principles should be followed in the treatment of AIDS in both the individual and the community:

1. Causes and sources should be pointed out. 2. Diagnosis should be made based on clinical and laboratory findings. 3. Avoid as much as possible exposure to immunological stressor or oxidizing agents. 4. Detoxification of already intoxicated body systems including the immune system. 5. Stimulate the weakened immune system and all other systems that may already be weak. 6. Provide specific treatment for the clinical manifestations of AIDS. 7. Participation of complementary practitioners and indigenous healers must be encouraged.

Let us look at them very briefly:

To this day the medical establishment and mainstream researchers have offered no effective answers as to how to treat and heal AIDS. They have concentrated their efforts on trying to stop replication of "the virus" that supposedly causes AIDS. Everything seems to indicate that they have been attacking the wrong cause (1-13).

Treatment would be completely different if the cause of AIDS was not HIV but rather immunological stressor or oxidizing agents. The two approaches are antagonistic.

The principles listed here propose treating AIDS as a toxic/nutritional degenerative condition and not as a sexually transmitted viral disease. In my previous postings I provided many scientific arguments demonstrating that AIDS is a toxic-nutritional syndrome caused by the alarming worldwide increment in immunological stressor or oxidizing agents (7-14).

The real causes should be explained in detail to the patient and to the community. Understanding this will contribute effectively to overcoming AIDS. People and patients should know that they can be exposed to immunological stressors through involuntarily conditions of life and through voluntarily life styles (7-12).

It is absolutely necessary to set aside the CDC/WHO definitions of AIDS, as well as the Bangui definition for African countries, which consider AIDS an infectious and contagious illness (15-17). This misleading approach precludes conducting an objective evaluation of the patient or the community. See my proposal for the definition of AIDS in my posting "The causes of AIDS" (9,12).

The health status of a given patient or community should be evaluated carefully by conventional clinical and laboratory techniques. Complementary or holistic techniques may be useful as well (18-23).

Conventional laboratory tests should be carried out to evaluate the physiologic status of all body systems and especially the immune system. Excretion systems should be capable of guaranteeing the elimination of toxins, a central part of the treatment (21-23).

To confirm the status of the immune system several tests should be done. In addition to counting the CD4 T lymphocytes the various T and B lymphocyte subsets should be counted. It is very important to evaluate the functioning of all immunocompetent cells and phagocytes with tests such as lymphoblastotransformation, inhibition of migration, etc (22,24,25). It is necessary to determine the levels all complement components, betha 2 microglobulin, as well as to check for protein electrophoresis, immunoelectrophoresis, quantitation of serum immunoglobulins (G, A, M, D, E), check for a variety of autoantibodies, circulating immune complexes, and perform skin tests with various antigens (22,26-29).

Evaluation of the nutritional status is critical. Test to determine the levels of macro and micronutrients should be conducted. Levels of B complex vitamins, vitamin A, C, and E, selenium, iron, and zinc should be evaluated (30-32).

The clinical status of the main endocrine glands ¾ pituitary, thyroid, adrenals, gonads ¾ should be evaluated. Tests determining liver and kidney functioning are also important. Endocrine glands, liver, and kidneys all play important roles in the detoxification and healing processes (21-23).

It is necessary to search clinically and through laboratory tests for the presence of the clinical manifestation of AIDS; opportunistic infections, tumors, and metabolic disturbances. The number and severity of these should be evaluated (21-23,33,34).

It is absolutely necessary to evaluate the level of intoxication or degree of oxidation of the immune system and of all other body systems (24,35). Since AIDS is a condition caused by an excess on free radicals, especially oxidizing species, it is absolutely necessary to evaluate the oxidative status by means of the modern tests available to determine the biomarkers of oxidative stress (36-43).

If so called "tests for HIV" – ELISA, Western blot, P 24 antigen, PCR, or viral load – are performed, their reactivity should be interpretated to mean intoxication rather than meaning "infected with HIV". See my posting: "Tests for HIV are highly inaccurate" (13).

When treating AIDS, present and past exposure to immunological stressor agents should be investigated with meticulous care (see my posts on "The Natural History of AIDS" and "Co-factors cause AIDS" for a list of the main immunological stressors in the groups at risk for AIDS in developed and underdeveloped countries).

Detailed explanations on how and why to avoid exposure to these agents should be given to the patient and to the community (8,9,11,12).

It is absolutely necessary to convince the patient and the community that they are not infected with "the virus that causes AIDS". The feeling of being infected with the virus that supposedly causes AIDS, in addition to being an immunological stressor, blocks participation of brain and mind in the healing process (44-49). The "HIV/AIDS hysteria" must be stopped immediately.

It is critical to convince the patient and the community that AIDS is no longer a mortal disease, as has been said for so many years, and that it is both easy and absolutely possible to cure it and to recover from it (50-52). Logically, healing and recovering processes depend on the degree of deterioration of tissues, organs, and body systems.

There is today a flowering of natural non-toxic measures to detoxify patients with AIDS through complementary, holistic, or alternative therapies (53-59).

Following are some of the measures that have been reported to have benefits in the detoxification process of patients with AIDS:

· Antioxidants: The role of oxidizing agents in the genesis of AIDS has been pointed out in scientific detail since the beginning of the epidemic (1-3,8,11,60-83). As a consequence, several antioxidant substances and compounds, such as vitamin C, A, and E, gluthatione, cysteine, zinc, selenium, etc., have been used with success in the treatment of AIDS (54,60,84-95).

· Nutrition: The correction of any nutritional abnormality and disturbance may be achieved in order to overcome AIDS in the patient and in the community. Several diets and nutritional interventions have been used in AIDS with success (96-103).

· Other therapies: Following are some of the non-toxic therapeutic approaches that have been reported to have substantial benefits in the treatment of AIDS; acupunture, digitopunture, Chinise traditional medicine, herbal medicine, Indian ayurvedic medicine, hyperthermia, oxygen therapy, massage therapy, homeopathy, naturopathic and colon therapy, music therapy, color therapy, gem therapy, aromatherapy, hypnosis therapy, light therapy, yoga, magnetic field therapy, orthomolecular medicine, cell therapy, and spiritual care (54,104-111).

Several immunomodulators and immune system stimulants have been used with success in the treatment of AIDS (112,113).

Several of the most often used are: interferons, interleukines, and growth factors, (112); B-complex vitamins (114); lithium (115,116); herbs such as ginsengs, eleuthero, sarsaparilla, sassafras, ashwagandha, Chinese cucumber, curcumin, catharanthus, podophyllum, pacific yew, mistletoe, echinacea, Aloe vera, garlic, Uncaria tomentosa (58,90,105,113).

Coping with mental stress is critical to both detoxification and stimulation of the weakened immune and other systems (46-48,117).

There are excellent publications that may be useful as guides for the effective treatment of AIDS (20,50,51-54,59,60,78,95,102).

Once the diagnosis of any of the opportunistic infections, tumors or metabolic conditions proper or common to the different groups of people at risk for AIDS has been made, the specific treatment available for them should be provided.

An optimal nutritional status for the patient or the community is absolutely necessary to overcome AIDS. Several publications can guide us in this important matter (96-102).

The medical establishment and mainstream researchers have concentrated their efforts on trying to stop replication of "the virus" that supposedly causes AIDS. On the other side, complementary practitioners and indigenous healers have been dealing with AIDS since its beginning from a different perspective. It is mandatory to consider these complementary approaches.

Besides, the popularity of complementary or alternative therapies in AIDS is exceeding all estimations. This is one of the reasons that the Unites States National Institutes of Health was compelled to establish the Office of Alternative Medicine [OAM] in 1991 (118).

For example, Bastyr University in Seattle, Washington, is an accredited educational institution that is getting founds from the Federal Government of The United States to search for alternative treatments for AIDS. The Natural Health Clinic of Bastyr University uses hyperhermia treatment for detox and to treat AIDS successfuly (20).

Any country that is serious and consistent in its commitment to overcoming AIDS should permit and stimulate the participation of indigenous natural healers in research and clinical fields. Indigenous healers should be a part of the teams treating and preventing AIDS.

If there remain doubts about the treatment of AIDS, the following trial is suggested to determine whether treatment with non-toxic measures is or is not more effective than the current official treatment with anti-retroviral medications.

Two groups of AIDS patients will be necessary: a) a group of patients will be treated with the official anti-retroviral treatment and; b) a second group will be treated by the non-toxic measures suggested in this post. Patients at different stages of AIDS would be necessary.

Both groups should be followed up for several years with clinical and laboratory evaluations of their health status.

1. Papadopulos-Eleopulos E. Reappraisal of AIDS - Is the Oxidation Induced by the Risk Factors the Primary Cause? Medical Hypothesis 1988; 25: 151-162.
2. Papadopulos-Eleopulos E. Looking Back on the Oxidative Stress Theory of AIDS. Continuum (London) 1998/9; 5(5); 30-35.
3. Papadopulos-Eleopulos E, Turner V, Papadimitriou JM. Oxidative Stress, HIV and AIDS. Res Immunol 1992; 143: 145-148.
4. Duesberg PH. AIDS Acquired by Drug Consumption and other Noncontagious Risk Factors. Pharmac Ther 1992; 55:201-277.
5. Duesberg PH, Rasnick D. The Drug-AIDS Hypothesis. Continuum (London) 1997; 4(5); S1-S24.
6. Duesberg PH, Rasnick D. The AIDS Dilema. Drug Diseases Blamed on a Passenger Virus. Genetica 1998; 104: 85-132.
7. Giraldo RA. AIDS and Stressors I: Worldwide Rise of Immunological Stressors. Toxicology Letters Supplement 1/78. 1995: s34.
8. Giraldo RA. AIDS and Stressors II: A Proposal for the Pathogenesis of AIDS. Toxicology Letters Supplement 1/78. 1995: s34.
9. Giraldo RA. AIDS and Stressors III: A Proposal for the Natural History of AIDS. Toxicology Letters Supplement 1/78. 1995: s35.
10. Giraldo RA. AIDS and Stressors I: Worldwide Rise of Immunological Stressors. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 23-56.
11. Giraldo RA. AIDS and Stressors II: A Proposal for the Pathogenesis of AIDS. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 57-96.
12. Giraldo RA. AIDS and Stressors III: A Proposal for the Natural History of AIDS. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 97-131.
13. Giraldo RA et al. Is It Rational To Treat or Prevent AIDS with Toxic Antiretrovital Drugs in Pregnant Women, Infants, Children, and Anybody Else? The Anser is Negative. Continuum (London) 1999; 5(6); 38-52.
14. Giraldo RA. AIDS and Stressors: AIDS in Neither an Infectious Disease nor is Sexually Transmitted. It is a Toxic-Nutritional Syndrome Caused by the Alarming Worldwide Increment of Immunological Stressor Agents. Medellín, Colombia: Impresos Begón, 1997; 205.
15. CDC. Centers for Disease Control and Prevention. Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome. JAMA 1987; 258: 1143-1154.
16. CDC. Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection & Expanded Surveillance Case Definition for AIDS Among Adolescents & Adults. MMWR 1992; 41: 1-19.
17. De Cock KM et al. AIDS Surveillance in Africa: A Reappraisal of Case Definition. BMJ 1991; 303: 1185-1189.
18. Null G. The Complete Guide to Health and Nutrition. New York: Delacorte Press; 1986; 608.
19. Chaitow L. Body/Mind Purification Program. New York: Simon and Schuster/Gaia; 1990.
20. Goldberg B. Detoxification Therapy. AIDS. En: Alternative Medicine. The Definitive Guide. Fife, Washington: Future Medicine Publishing Inc.; 1994; 156-166 and 494-509.
21. Tietz NW. Clinical Guide to Laboratory Tests. 3^rd Edition. Philadelphia: W.B. Saunders Co., 1995: 1096.
22. Fleisher TA. Evaluating Immunologic Function. En: Rich RR et al. Clinical Immunology. Principles and Practice. Section Eleven. St. Louis: Mosby, 1996; 2083-2087.
23. Cherneckey CC, Berger BJ. Laboratory Tests and Diagnostic Procedures. 2^nd Edition. Philadelphia: W.B. Sounders Co.; 1997; 1082.
24. Holsapple MP, Kaminski NE, Pruett SB. T Lymphocyte Subpopulations and Immunotoxicology of Drugs of Abuse. En: Kimber I, Selgrade MK. T Lymphocyte Subpopulations in Immunotoxicology. Chichester: John Wiley & Sons; 1998; 73-102.
25. Cavanaugh BM. Tests for Lymphocyte Functions. Nurse’s Manual of Laboratory and Diagnostic Tests. 3^rd Edition. Philadelphia: F.A. Davis Co.; 1999a; 82-94.
26. McPherson RA, Nakamura RM. Laboratory Immunology I. Clinic in Laboratory Medicine 1992a; 12(1); 1-162.
27. McPherson RA, Nakamura RM. Laboratory Immunology II. Clinic in Laboratory Medicine 1992b; 12(2); 163-392.
28. Cavanaugh BM. Test for the Complement System. Nurse’s Manual of Laboratory and Diagnostic Tests. 3^rd Edition. Philadelphia: F.A. Davis Co.; 1999b; 94-97.
29. Cavanaugh BM. Autoantibody tests. Nurse’s Manual of Laboratory and Diagnostic Tests. 3^rd Edition. Philadelphia: F.A. Davis Co.; 1999c; 98-102.
30. Hass E. Staying Healthy with Nutrition. Berkeley, CA: Celestial Arts; 1992.
31. Steinman D. Diet for a Poisoned Planet. How to Choose Safe Food for You & Your Family. New York: Ballantine Books; 1992; 400.
32. Labbe RF. Nutrition Support. Clinics in Laboratory Medicine 1993; 13(2); 323-530.
33. Gutierrez Y, Little MD. Diagnosis of Important Parasitic Diseases. Clinics in Laboratory Medicine 1996; 11: 811-1089.
34. Cavanaugh BM. Immunologic Tests Related to Cancer. Nurse’s Manual of Laboratory and Diagnostic Tests. 3^rd Edition. Philadelphia: F.A. Davis Co.; 1999d; 119-127.
35. Flaherty DK. Immunotoxicology and Risk Assessment. New York: Kluwer Academic/Plenum Publishers, 1999: 382.
36. Simic MG. Urinary Biomarkers and the Rate of DNA Damage In Carcinogenesis and Anticarcinogenesis. Mutat Res 1992; 267: 277.
37. Simic MG. DNA Markers of Oxidative Processes in Vivo: Relevance to Carcinogenesis and Anticarcinogenesis. Cancer Res (Suppl) 1994; 54: 1918s.
38. Simic MG, Bergtold DS. Dietary Modulation of DNA damage in Human. Mutat Res 1991; 250: 17.
39. Bashir S et al. Oxidative DNA Damage and Cellular Sensitivity to Oxidative Stress in Human Autoimmune Diseases. Ann Rheum Dis 1993; 52: 639.
40. Favier A. The Place of Oxygen Free Radicals in HIV Infections. A collection of papers presented at a conference on "The place of oxygen free radicals in HIV infection", Les Deux Alpex, France, January 1993. Chem Biol Interac 1994; 91: 91-100.
41. Vigue CA et al. Antioxidant Status and Indixes of Oxidative Stress During Consecutive Days Exercise. J Appl Physiol 1993; 75: 566.
42. Tagesson C et al. Determination of Urinary 8-Hydroxydeoxyguanosine by Automated Coupled-Column High Performance Liquid Chromatography: A Powerful Technique for Assaying in Vivo Oxidative DNA Damage in Cancer Patients. Eur J Cancer 1995; 31A :934.
43. Jovanovic S. Biomarkers of Oxidative Stress in Clinical Practice. Townsend Letter for Doctors & Patients 1998 (August/September); 72-76.
44. Kiecolt-Glaser JK, Glaser R. Psychological Influences on Immunity. Implications for AIDS. Amer J Psychol 1988; 43: 892-899.
45. Stein M, Miller AH. Stress, the Immune System and Health and Illness. En: Goldberg L, Bretznitz S. Handbook of Stress: Theoretical and Clinical Aspects. New York: McMillan; 1993.
46. Kemeny ME. Psychoimmunology of HIV Infection. In: Zegan LS, Coates TJ. Psychiatric Manifestations of HIV Disease. Psychiatric Clinics of North America 1994; 17: 55-68.
47. Schedlowski M, Tewes U. Psychoneuroimmunology. An Interdisciplinary Introduction. New York: Kluwer Academic/Platinum Publishers; 1999; 582.
48. Schneitherman N, et al. Psychoneuroimmunology and HIV/AIDS. In: Schedlowski M, Tewws U. Psychoneuroimmunology. New York: Kluwer Academic/Plenum Publishers 1999; 487-508.
49. Irvin M, Friedman E. Does Psychological Depression Cause Immune Suppression in Humans? En: Schedlowski M, Tewes U. Psychoneuroimmunology. An Interdisciplinary Introducction. Chapter 17. New York: Kluwer Academic/Plenum Publishers; 1999; 327-340.
50. Callen M. Surviving AIDS. New York: Harper Collins; 1990.
51. Chaitow L. You don’t have to die. Unraveling the AIDS Myth. Future Medical Publishers; 1994; 325.
52. Byrnes SC. Overcoming AIDS with Natural Medicine. Honolulu: Centaur Books; 1997; 219.
53. Pearsall P. Superimmunity. Master Your Emotions & Improve your Health. New York: Fawcett Gold Medal; 1987; 461.
54. Brighthope I. The AIDS Fighters. The Role of Vitamin C and other Immunity-Building Nutrients. New Canaan, Connecticut: Keats Publishing; 1988; 184.
55. Hand R. Alternative Therapies Used by Patients with AIDS. NEJM 1989; 320: 672-673.
56. Abrams DL. Alternative Therapies. In: Repoza NP. HIV Infection and Disease. Monographs for Physicians and other health care workers. Chicago: AMA Press, 1989.
57. Abrams DL. Alternative Therapies in HIV Infection. AIDS 1990; 4: 1179-1187.
58. Abrams DL. Dealing with Alternative Therapies for HIV. In Sande MA & Volverding PA. The Medical Management of AIDS. Philadelphia: WB Saunders Company; 1995: 183-207.
59. Badgley L. Healing AIDS Naturally: Natural Therapies for the Immune System. Foster City, California: Human Energy Press; 1990; 410.
60. Cathart R. Vitamin C in the Treatment of Acquired Immune Deficiency Syndrome (AIDS) Med Hypothesis 1984; 14: 423.
61. Dworkin BM. Selenium Deficiency in HIV Infection and the Acquired Immune Deficiency Syndrome (AIDS). Chem Biol Interact 1994; 91: 181-186.
62. Dworkin B, Rosenthal W, Wormser G, Weiss L. Selenium Deficiency in the Acquired Immuno-Deficiency Syndrome. J Parenteral Enteral Nutr 1986; 10: 405.
63. Staal FJT et al. Intracellular Glutathione Levels In T-Cells Subsets Decrease in the Blood Plasma of HIV-1 Infected Patients. Biol Chem Hoppe Seyler 1989; 370: 101-108.
64. Buhl R et al. Systemic Gluthation-Deficiency in Symptom-Free Seropositive Individuals. Lancet 1989; ii: 1294-1298.
65. Turner VF. Reducing Agents and AIDS - Why Are We Waiting? Med J Austr 1990; 153: 502.
66. Walter R, et al. Zinc Status in Human Immunodeficiency Virus Infection. Life Sci 1990; 47: 1579.
67. Fuchs J et al. Oxidative Inbalance in HIV Infected Patients. Medical Hypothesis 1991; 36:60-64.
68. Girelli A et al. Serum Selenium Concentration and Disease Progress in Patients with HIV-Infection. Clin Biochem 1991; 24: 211-214.
69. Graham N et al. Relationship of Serum Cooper and Zinc Levels to HIV-1 Seropositivity and Progression to AIDS. J AIDS 1991; 4: 976.
70. Halliwell B, Cross C. Reactive Oxygen Species, Antioxidants and Acquired Immunodeficiency Syndrome. Arch Intern Med 1991; 151: 29-31.
71. Quey B, Malinverni R, Lautenburg BH. Glutathione Depletion in HIV-Infected Patients: Role of Cysteine Deficiency and Effect of Oral N-Acetyl-Cysteine. AIDS 1992; 5: 814.
72. Salvain B, Mark AW. The Role of Oxidative Stress in Disease Progression in Individuals Infected by the Human Immunodeficiency Virus. J Leukocyte Biol 1992; 52: 111.
73. Dorge W, Eck HL, Mihm S. HIV-Induced Cysteine Deficiency and T-Cell Dysfunction: A Rationale for Treatment with N-Acetylcysteine. Immunol Today 1992; 13: 211.
74. Greenspan HC. The Role of Oxidative Oxygen Species, Antioxidants and Phytopharmaceuticals in Human Immunodeficiency Virus Activity. Med Hypothesis 1993; 40: 85.
75. Greenspan HC, Arouma O. Oxidative Stress and Apoptosis in HIV Infection: A Role for Plant-Derived Metabolites with Synergistic Antioxidant Activity. Immunol Today 1994; 15: 209.
76. Polyakov VM et al. Superoxide Anion (O2-) Production and Enzymatic Disbalance in Peripheral Blood Cells Isolated from HIV-Infected Children. Free Radic Biol Med 1994; 16: 15-21.
77. Favier A et al. Antioxidant Status and Lipid Peroxidation in Patients Infected with HIV. Chem Biol Interac 1994; 91: 165-180.
78. Piette J et al. Molecular Mechanisms of Virus Activation by Free Radicals. Collection of 5 articles presented at a conference on "The place of oxygen free radicals in HIV infections", Les Deux Alpes, France, January 1993. Chemico-Biological Interactions 1994; 91:79-132.
79. Constants J et al. Faty Acids and Plasma Antioxidants in HIV-Positive Patients Correlation with Nutritional and Immunological Status. Clin Biochem 1995; 28: 421-426.
80. Passi S. Progressive Increase of Oxidative Stress in Advancing Human Immunodeficiency. Continuum (London) 1998; 5(4); 20-26.
81. Passi S et al. Study on Plasma Polyunsaturated Faty Acids and Vitamin E, and on Erythrocyte Glutathione Peroxidase in High Risk HIV Infection Categories and AIDS Patients. Clin Chem Enzym Comms 1993; 5: 169-177.
82. Shallenberger F. Selective Compartmental Dominance: An Explanation for a Nonifectious, Multifactorial Etiology for Acquired Immune Deficiency Syndrome (AIDS), and a Rationale for Ozone Therapy and other Immune Modulating Therapies. Med Hypothesis 1998; 50: 67-80.
83. Byrnes SC. Staying on Top of Oxidative Stress. Healthy and Natural Journal, Millenium Wellness Guide 1999b, en: sbyrnes@chaminade.edu, disponible en: http://www.powerhealth.net.
84. Burns JJ et al. Third Conference on Vitamin C. Ann NY Acad Sci 1987; 498: 1-538.
85. Javier JJ et al. Antiooxidant Micronutrients and Immune Function in HIV-1 Infection. FASEB Proc 1990; 4A: 940-945.
86. Block G et al. Vitamin C: A New Look. Ann Int Med 1991; 114: 909-910.
87. Semba RD, Graham NMH, Caiaffa WT. Increased Mortality Associated with Vitamin A Deficiency During Human Immunodeficiency Virus Type 1 Infection. Arch Intern Med 1993; 153: 2149-2154.
88. Bendich A. Role of Antioxidants in the Maintenance of Immune Function. En: Frei B. Natural Antioxidants in Human Health and Disease. Chapter IV, Immunity and Infection. San Diego: Academic Press; 1994; 447-467.
89. Schrauzer GN, Sacher J. Selenium in the Maintenance and Therapy of HIV-Infected Patients. Chem Biol Inter 1994; 91: 199.
90. Peterhans E. Oxidants and Antioxidants In Viral Diseases: Metabolic Regulation and Autotoxicity. In: Frei B. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press; 1994: 489-514.
91. Adam ES. Antioxidant Supplementation in HIV/AIDS. Nurse Pract 1995; 20: 8.
92. Zhang Z, Inserra PF, Watson RR. Antioxidants and AIDS. En: Garewal HS. Antioxidants and Disease Prevention. Boca Raton: CRC Press; 1997; 45-66.
93. Inserra PF, Ardestani SK, Ross Watsson R. Antioxidants and Immune Function. En: Garewal HS. Antioxidants and Disease Prevention. Boca Raton: CRC Press; Chapter 3; 1997; 19-30.
94. Schultz V, Hansel R, Tyler VE. Agents that Increase Resistance to Diseases: Adaptogens; Immune Stimulants; Botanical Antioxidants. En: Rational Phytotherapy. A Physician Guide to Herbal Medicine. Springer; 1998; 269-273, 273-281, 282-286.
95. Reid L. Oxidative Stress and Antioxidants. A Nutritional Perspective. Continuum (London) 1998; 5(3); 52-54.
96. Beisel WR. Single Nutrients and Immunity. Am J Clin Nutr 1982; 35: 417-468.
97. Beisel WR. The History of Nutritional Immunology. J Nutr Immunol 1991; 1: 62-78.
98. Delafuente JC. Nutrients and Immune Responses. Rheum Dis Clin North Amer 1991; 17: 203-212.
99. Watson RR. Nutrition and AIDS. Boca Raton: CRC Press, 1994.
100. Hickson JF. Diet and Nutrition for Optimal Immune Function. In: Bahl SM, Hickson JF. Nutritional Care for HIV-Positive Persons: A Manual for Individuals and Their Caregivers. Boca Raton: CRC Press, 1995; 1-36.
101. Passi S, De Luca C. Dietetic Advice for Immunodeficiency. Continuum (London) 1998/9; 5(5); 43-52.
102. Mahan LK, Escott-Stump S. Medical Nutrition Therapy for Human Immunodeficiency Virus (HIV) Infection and Acquired Immunedeficiency Syndrome (AIDS). En: Krause’s Food, Nutrition, and Diet Therapy. Chapter 40. Philadelphia: W.B. Saunders Company; 2000; 889-911.
103. Bahl SM & Hickinson JF. Nutritional Care for HIV-Positive Persons: A Manual for Individuals and Their Caregivers. Boca Raton: CRC Press, 1995.
104. Woods JA. Immune Responses to Acute Exercise: Practical Applications for Exercise Prescription. En: Rippe JM. Lifestyle Medicine. Blackwell Science; 1999; 1125-1139.
105. Atkins RC. Immune-Enhancing Herbs. Infection Fighters. En: Dr. Atkins’ Vita-Nutrient Solution. Nature’s Answer to Drugs. New York Fireside; 1999; 294-296 y 297-299.
106. Byrnes SC. Conquering Candidiasis Naturally. Continuum (London) 1999a; 5(6); 34-37.
107. Lee Y-K, Nomoto K, Salminen S, Gorbach SL. Handbook of Probiotics. New York: John Wiley & Sons, Inc.; 1999; 211.
108. Pedersen BK. HIV Infection: Exercise and Immune Function. En: Rippe JM. Lifestyle Medicine. Blackwell Science; 1999; 1149-1158.
109. Chaitow L, Martin S. A World Without AIDS. London: Thorsons Publishing Group; 1988.
110. Garewal HS et al. A Preliminary Trial of Beta-Carotene in Subjects Infected with the Human Immunodeficiency Virus. J Nutr 1992; E22: 728.
111. Harakeh S, Jariwalla RJ, Pauling L. Suppression of Human Immunodeficiency Virus Replication by Ascarbate in Chronically and Acutelly Infected Cells. Proc Natl Acad Sci U.S.A. 1990; 87: 7245.
112. Malkovsky M et al. Acquired Immunological Torerance of Foreign Cells is Impaired by Recombinant Interleukin 2 or Vitamin A Acetate. Proc Nat Acad Sci (USA) 1985; 82: 536-538.
113. Tyler VE. Herbs of Choice. The Therapeutic Use of Phytomedicinals. Chapter 12: Performance and Immunedeficiencies. New York: Pharmaceutical Products Press, 1994: 171-186.
114. Robson EC, Schwartz MR. Vitamin B6 Deficiency and the Lymphoid System: Effects of Vitamin B6 Deficiency in utero on the Immunological Competence of the Offspring. Cell Immunol 1975; 16: 145-156.
115. Da Prato RA, Rothschild J. The AIDS Virus is an Opportunistic Organism Inducing a State of Chronic Relative Cortisol Excess: Therapeutic Implications. Med Hypoth 1986; 21: 253-266.
116. Flemenbaum A, Giraldo RA. Lithium for the Prevention, Treatment and Cure of AIDS. The Second World Congress on Drugs and Alcohol. Ramat Gam, Israel, November 13-17, 1988.
117. Lewis CE, O’Sullivan C, Barraclough J. The Psychoimmunology of Cancer: Mind and Body in the Fight for Survival? Oxford: Oxford University Press, 1994.
118. National Institutes of Health (HIH). Alternative Medicines: Expanding Medical Horizons. Workshop on Alternative Medicine. Chantilly, Virginia, September 14-16, 1992. Washington: US Government Press, 1994.